As of November 2024 Recursion Pharmaceuticals has a market cap of A$3.60 Billion. This makes Recursion Pharmaceuticals the world's 4000th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 20th, 2024 the market cap of Recursion Pharmaceuticals was reported to be: